BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 21647008)

  • 21. Efficacy of aprepitant in management of chemotherapy-induced nausea and vomiting.
    Osorio-Sanchez JA; Karapetis C; Koczwara B
    Intern Med J; 2007 Apr; 37(4):247-50. PubMed ID: 17388865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of nausea and vomiting caused by anticancer drugs: state of the art.
    Pisters KM; Kris MG
    Oncology (Williston Park); 1992 Feb; 6(2 Suppl):99-104. PubMed ID: 1532744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Importance of nausea.
    Jenns K
    Cancer Nurs; 1994 Dec; 17(6):488-93. PubMed ID: 7820827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A retrospective review of antiemetic use for chemotherapy-induced nausea and vomiting in pediatric oncology patients at a tertiary care center.
    Aseeri M; Mukhtar A; Al Khansa S; Elimam N; Jastaniah W
    J Oncol Pharm Pract; 2013 Jun; 19(2):138-44. PubMed ID: 23034405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aprepitant: a neurokinin-1 receptor antagonist for the treatment of chemotherapy-induced nausea and vomiting.
    Navari RM
    Expert Rev Anticancer Ther; 2004 Oct; 4(5):715-24. PubMed ID: 15485308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemotherapy-induced nausea and vomiting: state of the art in 2006.
    Schwartzberg L
    J Support Oncol; 2006 Feb; 4(2 Suppl 1):3-8. PubMed ID: 16499138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patient-practitioner perception gap in treatment-induced nausea and vomiting.
    Vidall C; Sharma S; Amlani B
    Br J Nurs; 2016 Sep; 25(16):S4-S11. PubMed ID: 27615540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The efficacy and cost effectiveness of new antiemetic guidelines.
    Engstrom C; Hernandez I; Haywood J; Lilenbaum R
    Oncol Nurs Forum; 1999 Oct; 26(9):1453-8. PubMed ID: 11064877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A nurse-led evidence-based practice project to monitor and improve the management of chemotherapy-induced nausea and vomiting.
    Underhill ML; Chicko L; Berry DL
    Clin J Oncol Nurs; 2015 Feb; 19(1):38-40. PubMed ID: 25689647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of chemotherapy-related nausea and vomiting using a serotonin antagonist.
    Egan AP; Taggart JR; Bender CM
    Oncol Nurs Forum; 1992 Jun; 19(5):791-5. PubMed ID: 1535124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimizing treatment outcomes in patients at risk for chemotherapy-induced nausea and vomiting.
    Thompson N
    Clin J Oncol Nurs; 2012 Jun; 16(3):309-13. PubMed ID: 22641323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent advances and updated guidelines in the management of chemotherapy-induced nausea and vomiting.
    Schwartzberg LS; Grunberg SM; Kris MG
    Clin Adv Hematol Oncol; 2011 Nov; 9(11 Suppl 27):1-14; quiz 15-6. PubMed ID: 22362372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiemetic effectiveness and nausea and vomiting incidence during capecitabine and oxaliplatin chemotherapy.
    Chan A; Tan SH; Low XH; Yap KY
    Nurs Res; 2012; 61(6):405-12. PubMed ID: 22960588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemotherapy-induced nausea and vomiting: challenges and opportunities for improved patient outcomes.
    Hawkins R; Grunberg S
    Clin J Oncol Nurs; 2009 Feb; 13(1):54-64. PubMed ID: 19193549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Knowledge and practice among Hong Kong oncology nurses in the management of chemotherapy-induced nausea and vomiting.
    So WK; Chan DN; Chan HY; Krishnasamy M; Chan T; Ling WM; Lo JC; Aranda S
    Eur J Oncol Nurs; 2013 Jun; 17(3):370-4. PubMed ID: 23153452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nurses' perceptions of antiemetic effectiveness.
    Rhodes VA; McDaniel RW; Simms SG; Johnson M
    Oncol Nurs Forum; 1995 Sep; 22(8):1243-52. PubMed ID: 8532549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oncology Patient Evidence-Based Notes (OPEN): antiemetics for chemotherapy-induced nausea and vomiting.
    Cope D
    Clin J Oncol Nurs; 2003; 7(4):461-2. PubMed ID: 12929282
    [No Abstract]   [Full Text] [Related]  

  • 38. [Guidelines for prophylaxis and treatment of chemotherapy-induced nausea and vomiting].
    Durand JP; Madelaine I; Scotté F
    Bull Cancer; 2009 Oct; 96(10):951-60. PubMed ID: 19734117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemotherapy-induced nausea and vomiting: prevention, detection, and treatment--how are we doing?
    Grunberg SM
    J Support Oncol; 2004; 2(1 Suppl 1):1-10, inside back cover; quiz 11. PubMed ID: 16117016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathogenesis-based treatment of chemotherapy-induced nausea and vomiting--two new agents.
    Navari RM
    J Support Oncol; 2003; 1(2):89-103. PubMed ID: 15352652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.